Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children

BACKGROUND: Urinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based on treatment with praziquantel (PZQ). We report t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS Negl Trop Dis
Auteurs principaux: Riveau, Gilles, Schacht, Anne-Marie, Dompnier, Jean-Pierre, Deplanque, Dominique, Seck, Modou, Waucquier, Nawal, Senghor, Simon, Delcroix-Genete, Delphine, Hermann, Emmanuel, Idris-Khodja, Noureddine, Levy-Marchal, Claire, Capron, Monique, Capron, André
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300301/
https://ncbi.nlm.nih.gov/pubmed/30532268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006968
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires